Intelicare Holdings (ICR.AX) Stock Price

Intelicare Holdings Price

ASX·CLOSED
0.03
-0.0010 (-3.92 %)
Market closed

Revenue has compounded at 34.5% per year over the past 6 years to 1.58 M AUD. Intelicare Holdings's net margin stands at -141.7%, up from -470.1% several years earlier. The stock trades about 79% above its 52-week low.

Intelicare Holdings stock price

Volume
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Intelicare Holdings over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Intelicare Holdings stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Intelicare Holdings's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Intelicare Holdings Stock Price History
DateIntelicare Holdings Price
9/14/20260.03 AUD
9/11/20260.03 AUD
9/10/20260.03 AUD
9/9/20260.03 AUD
9/8/20260.03 AUD
9/7/20260.03 AUD
9/4/20260.03 AUD
9/3/20260.03 AUD
9/2/20260.03 AUD
9/1/20260.03 AUD
8/31/20260.03 AUD
8/28/20260.03 AUD
8/27/20260.03 AUD
8/26/20260.03 AUD
8/25/20260.03 AUD
8/24/20260.02 AUD
8/21/20260.02 AUD
8/20/20260.02 AUD
8/19/20260.02 AUD
8/18/20260.03 AUD
8/17/20260.03 AUD
8/14/20260.03 AUD
8/13/20260.03 AUD
8/12/20260.02 AUD
8/11/20260.02 AUD
8/10/20260.02 AUD
8/7/20260.02 AUD
8/6/20260.02 AUD
8/5/20260.02 AUD
8/4/20260.02 AUD
Access this data via the Eulerpool API

Intelicare Holdings Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
1.24 M AUD
-3.93 M AUD
-3.93 M AUD
Jan 1, 2023
1.51 M AUD
-2.97 M AUD
-3.00 M AUD
Jan 1, 2024
1.22 M AUD
-2.17 M AUD
-2.26 M AUD
Jan 1, 2025
1.58 M AUD
-2.16 M AUD
-2.24 M AUD
Jan 1, 2026 (e)
100,000.00 AUD
0.00 AUD
0.00 AUD
Jan 1, 2027 (e)
800,000.00 AUD
0.00 AUD
0.00 AUD
Jan 1, 2028 (e)
2.10 M AUD
0.00 AUD
0.00 AUD
Jan 1, 2029 (e)
6.40 M AUD
0.00 AUD
0.00 AUD

Intelicare Holdings Income Statement, Balance Sheet, Cash Flow Statement

Last updated Sep 15, 2026, 6:08 PM
 
REVENUEM AUD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM AUD
EBITM AUD
EBIT MARGIN%
NET INCOMEM AUD
NET INCOME GROWTH%
SHARESM
20192020202120222023202420252026e2027e2028e2029e
1.001.001.001.002.006.00
200.00
100.00100.00100.00100.00100.00100.00
1.001.001.001.001.001.001.001.001.002.006.00
-2.00-4.00-3.00-2.00-2.00-2.00
-300.00-200.00-200.00-200.00
-2.00-4.00-3.00-2.00-2.00-2.00
100.00-25.00-33.33
83.7883.7885.49115.20166.45225.25454.72454.72454.72454.72454.72
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Intelicare Holdings generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Intelicare Holdings retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Intelicare Holdings's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Intelicare Holdings has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Intelicare Holdings's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Intelicare Holdings stock margins

The Intelicare Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Intelicare Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Intelicare Holdings.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
86.15 %
-469.21 %
-470.13 %
Jan 1, 2022
80.28 %
-316.07 %
-316.10 %
Jan 1, 2023
83.76 %
-196.93 %
-198.61 %
Jan 1, 2024
79.17 %
-177.81 %
-185.26 %
Jan 1, 2025
75.68 %
-136.36 %
-141.68 %
Jan 1, 2026 (e)
75.68 %
0.00 %
0.00 %
Jan 1, 2027 (e)
75.68 %
0.00 %
0.00 %
Jan 1, 2028 (e)
75.68 %
0.00 %
0.00 %

Intelicare Holdings Stock Revenue, EBIT, Earnings per Share

The Intelicare Holdings earnings per share therefore indicates how much revenue Intelicare Holdings has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
0.01 AUD
-0.05 AUD
-0.05 AUD
Jan 1, 2022
0.01 AUD
-0.03 AUD
-0.03 AUD
Jan 1, 2023
0.01 AUD
-0.02 AUD
-0.02 AUD
Jan 1, 2024
0.01 AUD
-0.01 AUD
-0.01 AUD
Jan 1, 2025
0.00 AUD
-0.00 AUD
-0.00 AUD
Jan 1, 2026 (e)
0.00 AUD
0.00 AUD
0.00 AUD
Jan 1, 2027 (e)
0.00 AUD
0.00 AUD
0.00 AUD
Jan 1, 2028 (e)
0.00 AUD
0.00 AUD
0.00 AUD

Intelicare Holdings business model & stock analysis

Intelicare Holdings Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Intelicare Holdings historical P/E ratio, EBIT multiple, and P/S ratio

Intelicare Holdings annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down Intelicare Holdings's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in Intelicare Holdings's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare Intelicare Holdings's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Intelicare Holdings shares outstanding

The number of shares of Intelicare Holdings was 454.72 M in 2025. This indicates how many shares Intelicare Holdings is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
85.49 M Stocks
Jan 1, 2022
115.20 M Stocks
Jan 1, 2023
166.45 M Stocks
Jan 1, 2024
225.25 M Stocks
Jan 1, 2025
454.72 M Stocks
Jan 1, 2026 (e)
454.72 M Stocks
Jan 1, 2027 (e)
454.72 M Stocks
Jan 1, 2028 (e)
454.72 M Stocks
Price targets and forecasts for Intelicare Holdings are not yet available.

Intelicare Holdings shareholder structure

% Name
7.42450%
Leach (Gregory David)
Leach (Gregory David)
5.33069%
Melbourne Securities Corporation Limited
Melbourne Securities Corporation Limited
3.58173%
Frontline Services Pty. Ltd.
Frontline Services Pty. Ltd.
3.31888%
Kyriaco Barber Pty. Ltd.
Kyriaco Barber Pty. Ltd.
3.23350%
Ratdog Pty. Ltd.
Ratdog Pty. Ltd.
3.22482%
Charlton Wa Pty. Ltd.
Charlton Wa Pty. Ltd.

Intelicare Holdings Executives and Management Board

8 members · 0 % women

JW

Mr. Jason Waller

Managing Director · since 2019

461,364.00 AUD

Management

NH

Mr. Neil Hackett

Company Secretary · since 2022

88,533.00 AUD
DP

Mr. Daniel Pilbrow

Chief Executive Officer

PK

Mr. Pieter Klopper

Chief Financial Officer

Board of Directors

GL

Mr. Greg Leach

Non-Executive Director · since 2022

52,533.00 AUD
NF

Dr. Neale Fong

Non-Executive Independent Chairman of the Board

TC

Mr. Tim Chapman

Interim Executive Director · since 2024

TS

Mr. Terry Sweeney

Non-Executive Director

Frequently asked questions about Intelicare Holdings

Converted at the current exchange rate, the Intelicare Holdings share trades at 0.02 EUR (0.03 AUD).

The Intelicare Holdings share (ICR.AX) is listed on 1 stock exchanges, including: ASX (ICR.AX).

No history available for Intelicare Holdings.

The expected revenue of Intelicare Holdings is 100,000.00 AUD. This figure is based on current financial data and reflects the company's business performance.

The profit cannot currently be calculated for Intelicare Holdings.

The P/E ratio cannot be calculated for Intelicare Holdings at the moment.

The price-to-sales ratio (P/S) of Intelicare Holdings is currently 113.68. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Intelicare Holdings stock.

The Eulerpool Quality Score for Intelicare Holdings is 3/10.

The ISIN of Intelicare Holdings is AU0000081788. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Intelicare Holdings is ICR.AX. The ticker symbol is used to trade Intelicare Holdings shares on the stock exchange.

Intelicare Holdings paid dividends every year for the past 0 years.

Intelicare Holdings is assigned to the 'Health' sector.

The dividends of Intelicare Holdings are distributed in AUD.

Fair ValuePRO
0.02 AUD
Over-/UndervaluationPRO
Fairly valued
Sector
Industry
Health Care Technology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Australia
Currency
AUD
Initial public offering
May 25, 2020
ISIN
AU0000081788
Cusip
Q49395108
Market capitalization
14.26 M AUDMicro Cap
52-Week Range
0.010.03AUD
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
P/E ratio
P/Ee 2026
P/Ee 2027
P/Ee 2028
P/Ee 2029
P/S
P/Se
104.59
EV/EBIT
P/B Ratio
15.02
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
1,924.79 %
Gross Margin
75.68 %
EBIT Margin
-136.36 %
Net Margin
-141.68 %
EPS (Earnings Per Share)
-0.00 AUD
Net Debt / EBIT
-0.14
Debt/Equity
-0.86
Last updated Sep 15, 2026, 6:08 PM

Intelicare Holdings Peer Group

Intelicare Holdings Ticker

ASX · ICR.AX

Intelicare Holdings FIGI

ICR:AU · BBG00TZMLWQ7ICR:AT · BBG00TZMLWR6ICR:AH · BBG00TZMLWW0